Cargando…
Current Guidelines for Management of Medullary Thyroid Carcinoma
Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor originating from the parafollicular cells. The diagnostic and therapeutic strategies for the condition are different from those used for well-differentiated thyroid cancer. Since the 2015 American Thyroid Association guidelines for the...
Autores principales: | Kim, Mijin, Kim, Bo Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Endocrine Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258323/ https://www.ncbi.nlm.nih.gov/pubmed/34154310 http://dx.doi.org/10.3803/EnM.2021.1082 |
Ejemplares similares
-
Recent Updates on the Management of Medullary Thyroid Carcinoma
por: Kim, Bo Hyun, et al.
Publicado: (2016) -
Management of medullary carcinoma of the thyroid: a
review
por: Jayasinghe, Ravindri, et al.
Publicado: (2022) -
Vandetanib for the Management of Advanced Medullary Thyroid Cancer: A Real-World Multicenter Experience
por: Kim, Mijin, et al.
Publicado: (2020) -
Introduction to European comments on “Medullary Thyroid Cancer: management guidelines of the American Thyroid Association”
por: Jarzab, Barbara, et al.
Publicado: (2013) -
Current status of the prognostic molecular markers in medullary thyroid carcinoma
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2020)